Work

Intermediate and high‐dose ARA‐C and m‐AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non‐Hodgkin lymphoma

Year: 1985

Type: article

Study design: Clinical Trial

Source: Scandinavian Journal of Haematology

DOI: 10.1111/j.1600-0609.1985.tb00748.x

Authors: R. Willemze, W. G. Peters, M. B. van Hennik, W. E. Fibbe, A. M. M. Kootte, M. van Berkel, R. Lie, C. J. Rodenburg, J. J. Veltkamp

Institution: Leiden University Medical Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1997420296

FWCI: 3.554

Cites: 13

Cited by: 37

Related to: 10